Pentostatin
Back to searchMolecule Structure
Scientific Name
Pentostatin
Description of the Drug
Pentostatin is an adenosine deaminase inhibitor used to treat hairy cell leukemia.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00552
http://www.drugbank.ca/drugs/DB00552
Brand Name(s)
Nipent, Pentostatin
Company Owner(s)
West-Ward Pharmaceuticals International Ltd, Hospira Inc, Rising Pharma Holding Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Adenosine deaminase | SINGLE PROTEIN | INHIBITOR | CHEMBL1910 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL2817 | ||||
| PharmGKB | PA450863 | ||||
| Human Metabolome Database | HMDB0014692 | ||||
| DrugBank | DB00552 | ||||
| PubChem: Thomson Pharma | 14848291 | 14823993 | 15221795 | 15221797 | |
| PubChem | 439693 | ||||
| NMRShiftDB | 60078726 | ||||
| Nikkaji | J10.843J | ||||
| PDBe | DCF | ||||
| BindingDB | 223291 | 22925 | |||
| EPA CompTox Dashboard | DTXSID2023436 | ||||
| DrugCentral | 2098 | ||||
| Brenda | 5147 | 5090 | 35853 | 43123 | 5440 |
| ChemicalBook | CB4746489 | ||||
| Guide to Pharmacology | 4805 | ||||
| rxnorm | PENTOSTATIN | NIPENT | |||
| PubChem: Drugs of the Future | 12013121 | ||||
| KEGG Ligand | C02267 | ||||
| ZINC | ZINC000003806262 |
